Abstracts tagged "ulcers and apremilast"

Abstract Number: 1695 • 2019 ACR/ARP Annual Meeting
Apremilast in Combination vs Monotherapy for Refractory Oral And/or Genital Ulcers in Behçet’s Disease: National Multicenter Study of 51 Cases
Belén Atienza-Mateo¹, Mónica Calderón-Goercke ², DIANA PRIETO- PENA ³, Iñigo Gonzalez-Mazon ³, Lara Sanchez-Bilbao ¹, Jose Luis Martín-Varillas ¹, Javier Loricera ⁴, Vanesa Calvo Río ¹, Jenaro Graña ⁵, Gerard Espinosa ⁶, Clara Moriano ⁷, Trinidad Pérez-Sandoval ⁷, Manuel Martín-Martínez ⁷, Elvira Díez ⁷, María Dolores García-Armario ⁸, Esperanza Martínez ⁸, Ivan Castellvi ⁹, Patricia Moya Alvarado ¹⁰, Francisca Sivera ¹¹, Jaime Calvo-Alen ¹², Isabel de la Morena ¹³, Francisco Ortiz-Sanjuán ¹⁴, José Andrés Román-Ivorra ¹⁴, Ana Pérez-Gómez ¹⁵, Sergi Heredia ¹⁶, Alejandro Olivé-Marqués ¹⁶, Águeda Prior-Español ¹⁷, Carolina Díez ¹⁸, Juan José Alegre-Sancho ¹⁹, Amparo Ybáñez ¹⁹, Ángels Martínez-Ferrer ¹⁹, Javier Narváez ²⁰, Ignasi Figeras ²¹, Ana Turrión ²², Susana Romero-Yuste ²³, Pilar Trénor ²⁴, Soledad Ojeda ²⁵, Miguel Á. González-Gay ²⁶ and Ricardo Blanco ²⁶, ¹Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain, ²Hospital Marqués de Valdecilla, Santander, Cantabria, Spain, ³Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, ⁴Rheumatology Department. Hospital Marqués de Valdecilla, Santander, Cantabria, Spain, ⁵Centro Médico Quirón A Coruña, A Coruña, Galicia, Spain, ⁶Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Barcelona, Catalonia, Spain, ⁷Complejo Asistencial Universitario de León, León, Castilla y Leon, Spain, ⁸Hospital Lluís Alcanyís, Xàtiva, Comunidad Valenciana, Spain, ⁹Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, ¹⁰Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain, ¹¹Hospital General Universitario de Elda, Elda, Spain, ¹²Hospital Universitario Araba, Vitoria-Gasteiz, Spain, ¹³Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain, ¹⁴Hospital Universitario y Politécnico La Fe, Valencia, Comunidad Valenciana, Spain, ¹⁵Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain, ¹⁶Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain, ¹⁷Hospital Universitari Germans Trias i Pujol, Badalona, Spain, ¹⁸Hospital de El Bierzo, León, Castilla y Leon, Spain, ¹⁹Hospital Universitario Doctor Peset, Valencia, Comunidad Valenciana, Spain, ²⁰Rheumatology Department, Hospital Universitari de Bellvitge, Barcelona, Catalonia, Spain, ²¹Hospital Bellvitge, Barcelona, Catalonia, Spain, ²²Hospital Clínico Universitario de Salamanca, Salamanca, Spain, ²³Complejo Hospitalario Universitario Pontevedra, Pontevedra, Galicia, Spain, ²⁴Hospital Clínico Universitario de Valencia, Valencia, Comunidad Valenciana, Spain, ²⁵Hospital Doctor Negrín, Las Palmas de Gran Canaria, Canarias, Spain, ²⁶Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
Background/Purpose: Oral and/or genital aphthous ulcers are the most common symptoms of Behçet´s disease (BD), and are often refractory to conventional treatment. The inhibitor of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].